Thereasa A. Rich

Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators

Montserrat Ayala‐Ramirez, Lei Feng, Marcella M. Johnson et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 419 citations · Full text

Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra‐adrenal paragangliomas

Montserrat Ayala‐Ramirez, Lei Feng, Mouhammed Amir Habra et al. · Cancer · 2011 · 156 citations · Full text

Use of the Tyrosine Kinase Inhibitor Sunitinib in a Patient with von Hippel-Lindau Disease: Targeting Angiogenic Factors in Pheochromocytoma and Other von Hippel-Lindau Disease-Related Tumors

Camilo Jiménez, Maria E. Cabanillas, Libero Santarpia et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 120 citations · Full text

The Characterization of Pheochromocytoma and Its Impact on Overall Survival in Multiple Endocrine Neoplasia Type 2

Sonali Thosani, Montserrat Ayala‐Ramirez, Lynn Palmer et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 118 citations · Full text

Expanding the clinical phenotype of hereditary <i>BAP1</i> cancer predisposition syndrome, reporting three new cases

Robert Pilarski, Colleen M. Cebulla, James B. Massengill et al. · Genes Chromosomes and Cancer · 2013 · 108 citations · Full text